Formulation of shea butter Nanoparticle containing griseofulvin: a combination of antifungal and anti-inflammatory treatments

Authors

  • Sidy Mouhamed Dieng Université de Thiès, laboratoire de pharmacie galénique & industrielle, UFR santé de Thiès, Thies, Sénégal Cité Malick SY BP 967 Thiès
  • Madieye Séne Université cheikh Anta Diop de Dakar, laboratoire de pharmacologie et pharmacodynamie, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Ahmedou Bamba Koueimel Fall Université cheikh Anta Diop de Dakar, laboratoire de pharmacie galénique & industrielle , Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Moussa Diop Université cheikh Anta Diop de Dakar, laboratoire de pharmacie galénique & industrielle , Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Papa Mady Sy Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Louis Augustin Diaga Diouf Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Alphonse Rodrigue Djiboune Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Mamadou Soumboundou Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Gora Mbaye Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Mounibé Diarra Université cheikh Anta Diop de Dakar, laboratoire de physique pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal
  • Oumar Thioune Université de Thiès, laboratoire de pharmacie galénique & industrielle, UFR santé de Thiès, Thies, Sénégal Cité Malick SY BP 967 Thiès

Abstract

Nanomedicine has been a booming industry with the development of nanovectors to encapsulate water-soluble or amphiphilic molecules for drug delivery. As the new therapeutic agents synthesized are increasingly lipophilic, the development of new nanoparticulate vectors allowing their transport and targeting is now a major challenge. These particles are lipid nanoparticles, a few hundred nanometers in diameter, stabilized by a layer of surfactants composed of castor oil and stealth agents. Solid lipid nanoparticles based on shea butter, stabilized by cremophor® ELP, encapsulating griseofulvin, were formulated by the temperature phase inversion method. The shea butter nanoparticles thus obtained were the subject of characterization relating to: determination of the morphology, size, polydispersity index, pH and zeta potential. The results confirm the stability of our preparations. The anti-inflammatory activity of shea butter being known, the tests were carried out on mice. The inflammation was induced by a solution of croton oil acetone. There is a very big improvement in anti-inflammatory activity. This is due to better penetration of the preparation through the different layers of the skin. Griseofulvin release studies have been carried out on our various preparations. Systems designed as reservoirs of active ingredients and intended for a priori controlled release obey kinetics of the order of one-half (½) corresponding to a proportionality between the quantity released and the square root of time. Shea butter in nanoparticulate forms has thus enabled us to considerably prolong the release of griseofulvin.

Keywords: Nanoparticles; Shea Butter; Inflammation; Griseofulvin.

Keywords:

Nanoparticles, Shea Butter, Inflammation, Griseofulvin

DOI

https://doi.org/10.22270/jddt.v11i2-S.4796

Author Biography

Moussa Diop, Université cheikh Anta Diop de Dakar, laboratoire de pharmacie galénique & industrielle , Faculté de Médecine, de Pharmacie et d’Odontologie Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal

Université cheikh Anta Diop de Dakar, laboratoire de pharmacie galénique & industrielle , Faculté de Médecine, de Pharmacie et d’Odontologie  Faculté de Médecine, de Pharmacie et d’Odontologie, BP: 5005, Dakar Fann, Sénégal

References

Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release Off J Control Release Soc. 2004; 99(1):53-62. doi:10.1016/j.jconrel.2004.06.015

Chen F, Ehlerding EB, Cai W. Theranostic nanoparticles. J Nucl Med Off Publ Soc Nucl Med. 2014; 55(12):1919-1922. doi:10.2967/jnumed.114.146019

Luengo J, Weiss B, Schneider M, et al. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol. 2006; 19(4):190-197. doi:10.1159/000093114

Müller-Goymann CC. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV. 2004; 58(2):343-356. doi:10.1016/j.ejpb.2004.03.028

Ting WW, Vest CD, Sontheimer RD. Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum. Int J Dermatol. 2004; 43(7):538-547. doi:10.1111/j.1365-4632.2004.02147.x

Demetzos C. Application of Nanotechnology in Drug Delivery and Targeting. In: Demetzos C, ed. Pharmaceutical Nanotechnology: Fundamentals and Practical Applications. Springer; 2016:77-145. doi:10.1007/978-981-10-0791-0_4

Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine Nanotechnol Biol Med. 2010; 6(1):9-24. doi:10.1016/j.nano.2009.04.008

Shrivastava P, Vyas S, Sharma R, et al. 20 - Nanotechnology for oral drug delivery and targeting. In: Mozafari M, ed. Nanoengineered Biomaterials for Advanced Drug Delivery. Woodhead Publishing Series in Biomaterials. Elsevier; 2020:473-498. doi:10.1016/B978-0-08-102985-5.00020-6

Sutradhar KB, Amin ML. Nanotechnology in Cancer Drug Delivery and Selective Targeting. ISRN Nanotechnology. doi:https://doi.org/10.1155/2014/939378

Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO. Nanotechnology for COVID-19: Therapeutics and Vaccine Research. ACS Nano. 2020; 14(7):7760-7782. doi:10.1021/acsnano.0c04006

Chowdhury A, Kunjiappan S, Panneerselvam T, Somasundaram B, Bhattacharjee C. Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases. Int Nano Lett. 2017; 7(2):91-122. doi:10.1007/s40089-017-0208-0

Din F ud, Aman W, Ullah I, et al. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine. 2017; 12:7291-7309. doi:10.2147/IJN.S146315

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021; 20(2):101-124. doi:10.1038/s41573-020-0090-8

Mohamed S, El-Sakhawy M, Sakhawy M. Polysaccharides, Protein and Lipid -Based Natural Edible Films in Food Packaging: A Review. Carbohydr Polym. 2020;238:116178. doi:10.1016/j.carbpol.2020.116178

Ribeiro LNM, Alcântara ACS, Rodrigues da Silva GH, et al. Advances in Hybrid Polymer-Based Materials for Sustained Drug Release. International Journal of Polymer Science. doi:https://doi.org/10.1155/2017/1231464

Thioune O, Dieng SM, Fall ABK, Diop M. Contribution of Nanotechnology In the Improvement of the Anti-Inflammatory activity of Shea butter. Published online 2020.

Yang S-J, Lin F-H, Tsai H-M, et al. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms. Biomaterials. 2011; 32(8):2174-2182. doi:10.1016/j.biomaterials.2010.11.039

Yhee JY, Son S, Kim SH, Park K, Choi K, Kwon IC. Self-assembled glycol chitosan nanoparticles for disease-specific theranostics. J Control Release Off J Control Release Soc. 2014; 193:202-213. doi:10.1016/j.jconrel.2014.05.009

Feng S-S. New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Nanomed. 2006; 1(3):297-309. doi:10.2217/17435889.1.3.297

Karlsson J, Vaughan HJ, Green JJ. Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments. Annu Rev Chem Biomol Eng. 2018;9:105-127. doi:10.1146/annurev-chembioeng-060817-084055

Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology. 2011; 9:55. doi:10.1186/1477-3155-9-55

Campani V, Giarra S, De Rosa G. Lipid-based core-shell nanoparticles: Evolution and potentialities in drug delivery. OpenNano. 2018; 3:5-17. doi:10.1016/j.onano.2017.12.001

Zhang M, Yang C, Yan X, Sung J, Garg P, Merlin D. Highly Biocompatible Functionalized Layer-by-Layer Ginger Lipid Nano Vectors Targeting P-Selectin for Delivery of Doxorubicin to Treat Colon Cancer. Adv Ther. 2019; 2(12):1900129. doi:https://doi.org/10.1002/adtp.201900129

Dieng SM, Anton N, Bouriat P, et al. Pickering nano-emulsions stabilized by solid lipid nanoparticles as a temperature sensitive drug delivery system. Soft Matter. 2019; 15(40):8164-8174. doi:10.1039/C9SM01283D

Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. Eur J Pharm Biopharm. 2018;133:285-308. doi:10.1016/j.ejpb.2018.10.017

Fonseca-Santos B, Silva PB, Rigon RB, Sato MR, Chorilli M. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration. Curr Med Chem. 2020; 27(22):3623-3656. doi:10.2174/0929867326666190624155938

Kanwar R, Rathee J, Salunke DB, Mehta SK. Green Nanotechnology-Driven Drug Delivery Assemblies. ACS Omega. 2019; 4(5):8804-8815. doi:10.1021/acsomega.9b00304

Katouzian I, Faridi Esfanjani A, Jafari SM, Akhavan S. Formulation and application of a new generation of lipid nano-carriers for the food bioactive ingredients. Trends Food Sci Technol. 2017; 68:14-25. doi:10.1016/j.tifs.2017.07.017

Thioune O, Fall A, Dieng SM, Moussa D. Focus On the Use of Shea Butter as Excipient For Ointment. Am J PharmTech Res. 2019; 9:254-266. doi:10.46624/ajptr.2019.v9.i6.022

Sène M, Barboza FS, Sarr A, Fall AD, Ndione Y, Y GYS. Healing and topical anti-inflammatory activities of the total aqueous bark extract of Combretum glutinosum Perr. (Combretaceae). J Med Plants Res. 2020; 14(5):215-224. doi:10.5897/JMPR2019.6879

Tardat-henry M, Beaudry JP. Librairie Lavoisier. Published 1992. Accessed February 25, 2021. https://www.lavoisier.fr/livre/environnement/chimie-des-eaux-2-ed/tardat-henry/descriptif_2267056

Alander J. Shea butter - a multifunctional ingredient for food and cosmetics. LIPID Technol. 2004; 16:202-205.

Maranz S, Wiesman Z, Garti N. Phenolic Constituents of Shea (Vitellaria paradoxa) Kernels. J Agric Food Chem. 2003; 51(21):6268-6273. doi:10.1021/jf034687t

Nurah OT, Julius IU. Optimization of Aqueous Extraction Conditions of Unrefined Shea Butter Using Response Surface Methodology. Am J Food Nutr. 2018; 6(4):108-114. doi:10.12691/ajfn-6-4-3

kapseu K, J NY, M P, M D, J D. Fatty acids and triglycerides of Cameroon shea butter. Riv Ital Delle Sostanze Grasse. 2001; 78(1):31-34.

Cevc G, Schätzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta BBA - Biomembr. 2002; 1564(1):21-30. doi:10.1016/S0005-2736(02)00401-7

Hansen S, Lehr C-M. Nanoparticles for transcutaneous vaccination. Microb Biotechnol. 2012; 5(2):156-167. doi:https://doi.org/10.1111/j.1751-7915.2011.00284.x

Prow TW, Grice JE, Lin LL, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 2011; 63(6):470-491. doi:10.1016/j.addr.2011.01.012

Published

2021-04-15
Statistics
Abstract Display: 885
PDF Downloads: 756
PDF Downloads: 584

How to Cite

1.
Dieng SM, Séne M, Fall ABK, Diop M, Sy PM, Diouf LAD, et al. Formulation of shea butter Nanoparticle containing griseofulvin: a combination of antifungal and anti-inflammatory treatments. J. Drug Delivery Ther. [Internet]. 2021 Apr. 15 [cited 2026 Jan. 29];11(2-S):59-65. Available from: https://www.jddtonline.info/index.php/jddt/article/view/4796

Issue

Vol. 11 No. 2-S (2021): Volume 11, Issue 2-S, March-April 2021

Section

Research

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

1.
Dieng SM, Séne M, Fall ABK, Diop M, Sy PM, Diouf LAD, et al. Formulation of shea butter Nanoparticle containing griseofulvin: a combination of antifungal and anti-inflammatory treatments. J. Drug Delivery Ther. [Internet]. 2021 Apr. 15 [cited 2026 Jan. 29];11(2-S):59-65. Available from: https://www.jddtonline.info/index.php/jddt/article/view/4796
Crossref
Scopus
Google Scholar
Europe PMC

Most read articles by the same author(s)